RELMADA THERAPEUTICS, INC. Common Stock, Value, Issued
RELMADA THERAPEUTICS, INC. (RLMD) had Common Stock, Value, Issued of $106.67 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-06
- 2026-06-30: Common Stock, Value, Issued $106.67K.
- 2026-03-31: Common Stock, Value, Issued $104.89K.
- 2025-12-31: Common Stock, Value, Issued $73.33K.
- 2025-09-30: Common Stock, Value, Issued $33.19K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $106.67K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $104.89K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $73.33K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $33.19K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $33.19K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $33.19K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $30.17K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $30.17K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $30.17K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $30.17K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $30.10K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $30.10K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $30.10K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $30.10K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $30.10K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $28.64K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $30.02K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $29.40K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $27.74K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $17.50K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $17.47K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $16.75K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $16.33K 10-K · filed 2022-03-25 | |
| 2020-09-30 | $16.19K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $15.85K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $14.94K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $14.46K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $9.94K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $9.74K 10-K · filed 2021-03-24 | $38.98K 10-K · filed 2019-09-24 |
| 2019-03-31 | $30.98K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $29.76K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $12.55K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.14K 10-KT · filed 2020-03-26 | $12.55K 10-K · filed 2018-09-28 |
| 2018-03-31 | $12.55K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $12.54K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $12.54K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $12.53K 10-K · filed 2018-09-28 | |
| 2017-03-31 | $12.04K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $12.04K 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $12.04K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $12.04K 10-K · filed 2017-09-28 | |
| 2016-03-31 | $12.02K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $12.00K 10-Q · filed 2016-02-05 | |
| 2015-09-30 | $11.01K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $10.78K 10-K · filed 2016-09-09 | |
| 2015-03-31 | $53.73K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $53.68K 10-Q · filed 2015-02-13 | |
| 2014-09-30 | $43.85K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $8.06K 10-K · filed 2015-09-11 | $40.29K 10-KT · filed 2014-09-09 |
| 2014-03-31 | $498.78K 8-K · filed 2014-05-27 | |
| 2014-02-28 | $28.50K 10-Q · filed 2014-04-15 | |
| 2013-12-31 | $4.96K 10-KT · filed 2014-09-09 | $495.88K 8-K · filed 2014-05-27 |
| 2013-11-30 | $28.50K 10-Q · filed 2014-01-13 | |
| 2013-08-31 | $28.50K 10-Q · filed 2014-04-15 | |
| 2013-05-31 | $23.50K 10-Q · filed 2013-07-12 | |
| 2013-02-28 | $23.50K 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $240.24K 8-K · filed 2014-05-27 | |
| 2012-08-31 | $23.50K 10-K · filed 2013-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |